A patient has multiple pruritic blackish papules on both upper and lower limbs and the neck for 4 months; what are the differential diagnoses, recommended diagnostic workup, and appropriate treatment options?

Multiple Pruritic Blackish Papules on Bilateral Limbs and Neck for 4 Months

Based on the clinical presentation of multiple pruritic blackish papules distributed symmetrically over bilateral upper and lower limbs and neck persisting for 4 months, the most likely diagnosis is chronic prurigo, and you should initiate treatment with topical high-potency corticosteroids combined with oral gabapentinoids or doxycycline while conducting targeted investigations to exclude underlying systemic causes.

Differential Diagnoses

The distribution pattern and chronicity point toward several key possibilities:

Primary Considerations:

• Chronic Prurigo (Prurigo Nodularis/Prurigo Simplex): Most likely given the 4-month duration, multiple pruritic papules/nodules, and bilateral symmetric distribution 1, 2, 3. The blackish appearance suggests post-inflammatory hyperpigmentation from chronic scratching.

• Prurigo Pigmentosa: Consider this if lesions show reticular pattern on trunk/neck with characteristic brownish pigmentation 4, 5. However, this typically affects back and chest more than limbs.

• Lichen Planus: Can present with pruritic violaceous papules but typically shows Wickham's striae and different distribution 5.

• Psoriasis (Guttate or Chronic Plaque): Multiple papules but usually with silvery scale, less commonly described as "blackish" 6, 7.

Secondary Considerations:

• Sweet's Syndrome: Tender inflammatory papules/nodules, typically upper limbs, face, neck - but usually associated with systemic symptoms 8.

• Cutaneous T-cell Lymphoma (Early Stage): Multiple papules with pruritus, but 4-month duration makes this less likely initially 9, 10.

Diagnostic Workup

Essential Initial Investigations:

Laboratory Tests:

• Complete blood count with differential (rule out eosinophilia, lymphoma)
• Comprehensive metabolic panel (liver, kidney function)
• Fasting glucose and HbA1c (diabetes association with prurigo)
• Thyroid function tests (TFTs) - only if clinical features suggest thyroid disease 11
• HIV serology (associated with prurigo nodularis) 12
• Hepatitis B and C serology (chronic liver disease association)

Skin Biopsy (Essential): Perform punch biopsy of representative lesion showing:

• For chronic prurigo: lymphocytic perivascular infiltrate, few eosinophils, possible spongiosis, acanthosis 1, 3
• For prurigo pigmentosa: neutrophilic infiltrate (early), spongiosis, necrotic keratinocytes 4, 5
• Rule out lymphoma: atypical lymphocytes, epidermotropism 9, 10

Additional Investigations if Initial Tests Unrevealing:

• Chest X-ray (exclude sarcoidosis, lymphoma, tuberculosis)
• Serum protein electrophoresis (if age >50 years)
• Stool examination for parasites (if travel history or eosinophilia)

Do NOT routinely screen for occult malignancy unless systemic symptoms present 11.

Treatment Algorithm

First-Line Treatment (Initiate Immediately):

Topical Therapy:

• High-potency topical corticosteroids (clobetasol propionate 0.05% cream) applied to lesional skin twice daily 13, 1
• Capsaicin 0.025% cream four times daily for severe pruritus 11, 2
• Topical calcineurin inhibitors (tacrolimus 0.1%) for face/neck lesions 2

Systemic Therapy - Choose ONE based on patient factors:

1. Gabapentinoids (Preferred for severe pruritus):

   • Gabapentin: Start 300 mg at bedtime, increase to 300 mg three times daily over 1 week, maximum 1800 mg/day 1, 2
   • OR Pregabalin: 75 mg twice daily, increase to 150 mg twice daily 1

2. Doxycycline (If prurigo pigmentosa suspected or inflammatory component):

   • 100 mg once daily for 2 months 4, 5

3. Antihistamines (Adjunctive only):

   • Sedating antihistamine at bedtime for sleep disturbance 1

Second-Line Treatment (If inadequate response after 4-6 weeks):

Phototherapy:

• Narrowband UVB three times weekly 14, 2
• PUVA if NB-UVB fails 14

Immunosuppressants:

• Methotrexate 10-15 mg weekly (monitor liver function) 2, 3
• OR Cyclosporine 3-5 mg/kg/day (monitor blood pressure, renal function) 2

Third-Line Treatment (Refractory cases):

Biologics (Preferred for eligible patients):

• Dupilumab: 600 mg loading dose, then 300 mg every 2 weeks - approved for chronic prurigo 1, 2
• Nemolizumab: If available, highly effective for pruritus 1, 2

JAK Inhibitors:

• Upadacitinib or other JAK inhibitors showing promise 15

Opioid Receptor Modulators:

• Naltrexone 50 mg daily 2

Critical Pitfalls to Avoid

1. Do not delay skin biopsy - Essential to exclude lymphoma and confirm diagnosis 9, 10, 3

2. Do not perform extensive malignancy screening unless systemic symptoms present - low yield and causes unnecessary anxiety 11

3. Do not use systemic corticosteroids as first-line - Risk of rebound and long-term complications outweigh benefits in chronic prurigo 1, 2

4. Do not ignore psychiatric comorbidity - Chronic prurigo significantly impairs quality of life; screen for depression/anxiety 12

5. Do not forget to assess for diabetes, obesity, thyroid disease, kidney disease - Common comorbidities requiring management 12

Follow-up and Monitoring

• Week 2: Assess treatment tolerance and early response
• Week 4-6: Evaluate efficacy using patient-reported itch severity (0-10 scale) and lesion count
• If no improvement by 6 weeks: Escalate to second-line therapy
• Monitor for treatment-related adverse effects: Liver function (methotrexate), blood pressure/creatinine (cyclosporine), infections (biologics)

Treatment success defined as: ≥50% reduction in pruritus intensity and lesion count with improved quality of life 1.